Grindeks AS operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other
pharmaceutical manufacturers in Europe:
Fine Foods & Pharmaceuticals NTM SpA
sales of 139.39 million Euro [US$151.01 million]
Dottikon ES Holding AG
(158.23 million Swiss Francs [US$161.30 million]
of which 91%
was Pharma Products), and
Alliance Pharma Plc
based in the United Kingdom
(£118.21 million [US$153.72 million]
of which 100%
During the year ended December of 2018, sales at
Grindeks AS were 145.48 million Euro (US$157.61 million).
increase of 9.9%
versus 2017, when the company's sales were 132.41 million Euro.
This was the third consecutive year of growth at Grindeks AS.
Sales of Final Dosage Forms saw an increase
10.0% in 2018, from
125.49 million Euro to 138.03 million Euro.